Molson Coors Decided to Reopen Its Offices. Things Got Complicated.
Molson Coors Beverage Co. learned some lessons after bringing corporate employees back to their offices in October. Color-coded wristbands can...
Molson Coors Beverage Co. learned some lessons after bringing corporate employees back to their offices in October. Color-coded wristbands can...
General Electric Co. , Union Pacific Corp. and other large employers have suspended Covid-19 vaccine requirements for workers after a...
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
Eli Lilly & Co.’s monoclonal antibody drug has been cleared for emergency use in children under the age of 12,...
A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early...
A federal jury in Cleveland on Tuesday found that the companies owning CVS, Walgreens and Walmart pharmacies were liable for...
The Food and Drug Administration on Friday cleared Covid-19 boosters from Pfizer Inc. and BioNTech SE and from Moderna Inc....
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
Merck & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low-...
A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
Johnson & Johnson’s JNJ 2.55% sales climbed in the latest quarter compared with the same stretch of last year, reflecting...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
WASHINGTON—Supply-chain disruptions and global health concerns spurred the International Monetary Fund to lower its 2021 growth forecast for the world...
Johnson & Johnson’s JNJ -0.42% top scientist, who oversaw a turnaround in the company’s pharmaceutical unit and the development of...
Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to...
Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings...